Cholesterol and the development of clear-cell renal carcinoma
Authors:
- Harry A DrabkinHarry A Drabkin
- Robert M GemmillRGRobert M Gemmill
- 1 December 2012
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 12 (6) , 742-750
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate PathwayCell, 2012
- Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor typesHuman Mutation, 2011
- Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 SignalingCancer Cell, 2011
- mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP PathwayCell, 2011
- AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant MiceCell Metabolism, 2011
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinomaNature, 2011
- Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genesNature, 2010
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF ExpressionCell, 2010
- SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell GrowthCell Metabolism, 2008
- pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2Molecular Cell, 2007